EUVIMEDEUVIMED entdecken
Crossref

Clinicopathological and genomic features of extrachromosomal DNA in gastric cancer

Yukio Hokazono, Mihoko Saito-Adachi, Natsuko Hama, Yasushi Totoki, Hiromi Nakamura, Yasuhito Arai, Shinichi Yachida, Akihiko Fukagawa, Hirofumi Rokutan, Tetsuo Ushiku, Tatsuhiro Shibata

Gastric Cancer · 2026-01 · 29 (1) · 27-38

DOI: 10.1007/s10120-025-01666-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gastric Cancer, online erschienen am 18.10.2025. Verfasst von Yukio Hokazono und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Genomics, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan. Hauptthemen laut MEDLINE: Stomach Neoplasms, DNA, Circular, Biomarkers, Tumor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development (AMED), National Cancer Center Research and Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Extrachromosomal DNA (ecDNA), a form of circular DNA located outside chromosomes, is a common driver of oncogene amplification. Recent pan-cancer studies have associated ecDNA with cancer progression and poor prognosis. Moreover, its relationship with specific genomic features is becoming increasingly evident. However, the clinicopathological characteristics and underlying genomic mechanisms of ecDNA in gastric cancer remain poorly understood. METHODS: We analyzed whole-genome sequencing data from 81 Japanese gastric cancer samples to identify ecDNA using AmpliconArchitect and AmpliconClassifier. Gene expression profiles were obtained through whole-transcriptome RNA sequencing (RNA-seq). RESULTS: We found that the frequency of ecDNA occurrence was comparable across cancer stages and had a modest impact on prognosis, suggesting that ecDNA is present in early-stage disease and has a limited role in gastric cancer progression. Several immunomodulatory genes were amplified on ecDNA, and the presence of ecDNA harboring these genes was associated with the suppression of cytotoxic T cell responses, indicating a functional link between ecDNA and immune evasion. ecDNA-positive cases more frequently harbored TP53 mutations and were microsatellite stable compared to ecDNA-negative cases. Finally, ecDNA-positive tumors exhibited a high prevalence of single-base substitution signature 17, implicating that oxidative stress, potentially induced by gastric acid, plays a role in the generation of ecDNA in gastric cancer. CONCLUSIONS: These findings provide insights into the clinicogenomic features of ecDNA in gastric cancer and highlight its potential impact on disease progression and immune modulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsDNA, CircularBiomarkers, TumorHumansMaleFemalePrognosisMiddle AgedAgedWhole Genome SequencingMutation

Stichwörter der Autor:innen

Gastric cancerGene amplificationGenomic structural variationWhole-genome sequencing

Substanzen

DNA, CircularBiomarkers, Tumor

Autor:innen und Institutionen

  • Division of Cancer Genomics, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
  • Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Laboratory of Molecular Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Department of Cancer Genome Informatics, Graduate School of Medicine, The University of Osaka, Osaka, Japan.
  • Department of Pathology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan.
  • Division of Cancer Genomics, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan. tashibat@ncc.go.jp.

Förderung

  • Japan Agency for Medical Research and Development (AMED)
  • National Cancer Center Research and Development Fund

Zitieren

APA

Hokazono, Y., Saito-Adachi, M., Hama, N., Totoki, Y., Nakamura, H., Arai, Y., Yachida, S., Fukagawa, A., Rokutan, H., Ushiku, T., & Shibata, T. (2026). Clinicopathological and genomic features of extrachromosomal DNA in gastric cancer. Gastric Cancer, 29(1), 27-38. https://doi.org/10.1007/s10120-025-01666-y

Vancouver

Hokazono Y, Saito-Adachi M, Hama N, Totoki Y, Nakamura H, Arai Y, et al. Clinicopathological and genomic features of extrachromosomal DNA in gastric cancer. Gastric Cancer. 2026;29(1):27-38. doi:10.1007/s10120-025-01666-y

BibTeX
@article{Hokazono2026,
  author = {Hokazono, Yukio and Saito-Adachi, Mihoko and Hama, Natsuko and Totoki, Yasushi and Nakamura, Hiromi and Arai, Yasuhito and Yachida, Shinichi and Fukagawa, Akihiko and Rokutan, Hirofumi and Ushiku, Tetsuo and Shibata, Tatsuhiro},
  title = {Clinicopathological and genomic features of extrachromosomal DNA in gastric cancer},
  journal = {Gastric Cancer},
  year = {2026},
  volume = {29},
  number = {1},
  pages = {27--38},
  doi = {10.1007/s10120-025-01666-y}
}
Kostenlos starten →